Study in Patients With COPD

• Status: Completed
• Trial end date: 2005-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective compared to the control drug.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dey
• Treatments: Formoterol Fumarate

Criteria

Inclusion Criteria:

-History of COPD and cigarette smoking

Exclusion Criteria:

• Clinical diagnosis of asthma.

• Chest X-ray that is diagnostic of a significant pulmonary disease other than COPD

• Disease of other major organ systems